Posterior Uveitis in Ocular-Involving Chronic Lymphocytic Leukemia and the Utility of Negative MYD88 L265P Testing in the Diagnosis

Overview

Journal Ocul Oncol Pathol

Date 2024 Jun 17

PMID 38882022

Authors

Daniel A Balikov

Noah A Brown

Victor M Elner

Thomas J Wubben

Rajesh C Rao

Hakan Demirci

Affiliations

Soon will be listed here.

Abstract

Introduction: The aim of this study was to investigate if a negative test result for L265P mutation, associated with vitreoretinal lymphoma (VRL) and primary CNS lymphoma, in liquid biopsies from intraocular fluids can be a useful adjuvant test to diagnose chronic lymphocytic leukemia in clinically challenging cases.

Case Presentations: We selected patients with a past medical history or examinations findings suspicious for intraocular lymphoma. We evaluated both vitreous and aqueous humor-derived (AHD) L265P mutation from patients that had suspected intraocular lymphoma that warranted a liquid biopsy procedure. Gold-standard cytopathology, flow cytometry, and gene rearrangement studies were also performed. All 4 patients had negative AHD L265P mutation testing. Gold-standard testing (cytology) either showed paucicellular specimens (1/4) or specimens with high background inflammation (3/4). One case showed a rare B-cell clonal population (CD5, Kappa-restricted by flow cytometry), but this was not sufficient to make any definitive diagnosis. All patients were subsequently initiated on systemic therapy and had improvement in their disease burden.

Conclusions: Negative AHD L265P mutation testing can serve as an adjuvant molecular test to diagnose difficult cases of intraocular CLL.

References

Kincaid M, Green W . Ocular and orbital involvement in leukemia. Surv Ophthalmol. 1983; 27(4):211-32. DOI: 10.1016/0039-6257(83)90123-6. View

Hattenhauer M, Pach J . Ocular lymphoma in a patient with chronic lymphocytic leukemia. Am J Ophthalmol. 1996; 122(2):266-8. DOI: 10.1016/s0002-9394(14)72022-7. View

Vermaat J, Somers S, de Wreede L, Kraan W, de Groen R, Schrader A . mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis. Haematologica. 2019; 105(2):424-434. PMC: 7012469. DOI: 10.3324/haematol.2018.214122. View

Currie J, Lessell S, LESSELL I, Weiss J, Albert D, Benson E . Optic neuropathy in chronic lymphocytic leukemia. Arch Ophthalmol. 1988; 106(5):654-60. DOI: 10.1001/archopht.1988.01060130708030. View

Sieburth R, Weaver C, Kirzhner M, Shildkrot Y . IBRUTINIB FOR CONTROL OF CHOROIDAL AND ORBITAL METASTASIS FROM CHRONIC LYMPHOCYTIC LEUKEMIA. Retin Cases Brief Rep. 2021; 17(2):120-122. DOI: 10.1097/ICB.0000000000001118. View

Visco C, Tanasi I, Quaglia F, Ferrarini I, Fraenza C, Krampera M . Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice. Cancers (Basel). 2020; 12(10). PMC: 7600909. DOI: 10.3390/cancers12102913. View

Hallek M, Shanafelt T, Eichhorst B . Chronic lymphocytic leukaemia. Lancet. 2018; 391(10129):1524-1537. DOI: 10.1016/S0140-6736(18)30422-7. View

Whitney C, Mathur S, Finch C . Chronic lymphocytic leukemia presenting with symptomatic central nervous system involvement. Ann Hematol. 2002; 81(7):402-4. DOI: 10.1007/s00277-002-0475-2. View

Balasubramaniam S, Salomao D, Davies J, Ramsay R, Habermann T, Chow G . Paraneoplastic sarcoid-like reactions and the eye. Retina. 2014; 35(4):789-97. DOI: 10.1097/IAE.0000000000000429. View

10.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun M . Cancer statistics, 2007. CA Cancer J Clin. 2007; 57(1):43-66. DOI: 10.3322/canjclin.57.1.43. View

11.

Borowitz M, Bigner S, Johnston W . Diagnostic problems in the cytologic evaluation of cerebrospinal fluid for lymphoma and leukemia. Acta Cytol. 1981; 25(6):665-74. View

12.

BRINCKER H . The sarcoidosis-lymphoma syndrome. Br J Cancer. 1986; 54(3):467-73. PMC: 2001616. DOI: 10.1038/bjc.1986.199. View

13.

Bonzheim I, Giese S, Deuter C, Susskind D, Zierhut M, Waizel M . High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates. Blood. 2015; 126(1):76-9. DOI: 10.1182/blood-2015-01-620518. View

14.

DUKE J, Wilkinson C, SIGELMAN S . Retinal microaneurysms in leukaemia. Br J Ophthalmol. 1968; 52(5):368-74. PMC: 506602. DOI: 10.1136/bjo.52.5.368. View

15.

Kikushige Y, Ishikawa F, Miyamoto T, Shima T, Urata S, Yoshimoto G . Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell. 2011; 20(2):246-59. DOI: 10.1016/j.ccr.2011.06.029. View

16.

Buchan J, McKibbin M, Burton T . The prevalence of ocular disease in chronic lymphocytic leukaemia. Eye (Lond). 2003; 17(1):27-30. DOI: 10.1038/sj.eye.6700277. View

17.

Moazzam A, Drappatz J, Kim R, Kesari S . Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review. J Neurooncol. 2011; 106(1):185-200. DOI: 10.1007/s11060-011-0636-z. View

18.

Khan K, Malik A, Almarzouqi S, Morgan M, Yalamanchili S, Chevez-Barrios P . Optic Neuropathy Due to Chronic Lymphocytic Leukemia Proven With Optic Nerve Sheath Biopsy. J Neuroophthalmol. 2015; 36(1):61-6. DOI: 10.1097/WNO.0000000000000300. View

19.

Demirci H, Rao R, Elner V, Demirci F, Axenov L, Betz B . Aqueous Humor-Derived MYD88 L265P Mutation Analysis in Vitreoretinal Lymphoma: A Potential Less Invasive Method for Diagnosis and Treatment Response Assessment. Ophthalmol Retina. 2022; 7(2):189-195. DOI: 10.1016/j.oret.2022.08.005. View

20.

Ngo V, Young R, Schmitz R, Jhavar S, Xiao W, Lim K . Oncogenically active MYD88 mutations in human lymphoma. Nature. 2010; 470(7332):115-9. PMC: 5024568. DOI: 10.1038/nature09671. View